| Title | Investigational New Drugs |
| Standard Abbreviation | Investig. New Drugs |
| Type of Publication | Journal |
| Discipline | Pharmacology (Q1); Pharmacology (medical) (Q1); Oncology (Q2) |
| Impact Score | 3.62 |
| SCImago Journal Rank (SJR) | 0.943 |
| h-index | 94 |
| Overall Rank | 4625 |
| Publisher Name | Kluwer Academic Publishers |
| Publication Country | Netherlands |
| International Standard Serial Number (ISSN) | 01676997, 15730646 |
| Coverage and History | 1983-2022 |
| Best Quartile | Q1 |
| Total Citations Received (Last 3 Year) |
1792 |
Investigational New Drugs is a journal published by Kluwer Academic Publishers. This journal covers the area[s] related to Pharmacology, Pharmacology (medical), Oncology, etc.
The coverage history of this journal is as follows: 1983-2022.
The rank of this journal is 4625. This journal's impact score, h-index, and SJR are 3.62, 94, and 0.943, respectively. The ISSN of this journal is/are as follows: 01676997, 15730646.
The best quartile of Investigational New Drugs is Q1.
This journal has received a total of 1792 citations during the last three years (Preceding 2022).
The latest impact score (IS) of the Investigational New Drugs is 3.62. It is computed in the year 2023 as per its definition and based on Scopus data.
3.62
It is decreased by a factor of around 0.27, and the percentage change is -6.94% compared to the preceding year 2021, indicating a falling trend.
The impact score (IS), also denoted as the Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact Score 2022 of Investigational New Drugs is 3.62. If a similar downward trend continues, IS may decrease in 2023 as well.
| Year | Impact Score (IS) |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 3.62 |
| 2021 | 3.89 |
| 2020 | 3.29 |
| 2019 | 3.52 |
| 2018 | 2.70 |
| 2017 | 3.69 |
| 2016 | 3.71 |
| 2015 | 3.71 |
| 2014 | 3.27 |
The h-index of Investigational New Drugs is 94. By definition of the h-index, this journal has at least 94 published articles with more than 94 citations.
The h-index (also known as the Hirsch index or Hirsh index) is a scientometric parameter used to evaluate the scientific impact of the publications and journals. It is defined as the maximum value of h such that the given Journal has published at least h papers and each has at least h citations.
The International Standard Serial Number (ISSN) of Investigational New Drugs is/are as follows: 01676997, 15730646.
The ISSN is a unique 8-digit identifier for a specific publication like Magazine or Journal. The ISSN is used in the postal system and in the publishing world to identify the articles that are published in journals, magazines, newsletters, etc. This is the number assigned to your article by the publisher, and it is the one you will use to reference your article within the library catalogues.
ISSN code (also called as "ISSN structure" or "ISSN syntax") can be expressed as follows: NNNN-NNNC
Here, N is in the set {0,1,2,3...,9}, a digit character, and C is in {0,1,2,3,...,9,X}
The Investigational New Drugs is ranked 4625 among 27955 Journals, Conferences, and Book Series.
As per SJR, this journal is ranked 0.943.
SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
The publisher of Investigational New Drugs is Kluwer Academic Publishers. The publishing house of this journal is located in the Netherlands. Its coverage history is as follows: 1983-2022.
Please check the official website of this journal to find out the complete details and Call For Papers (CFPs).
The International Organization for Standardization 4 (ISO 4) abbreviation of Investigational New Drugs is Investig. New Drugs. ISO 4 is an international standard which defines a uniform and consistent system for the abbreviation of serial publication titles, which are published regularly. The primary use of ISO 4 is to abbreviate or shorten the names of scientific journals using the technique of List of Title Word Abbreviations (LTWA).
As ISO 4 is an international standard, the abbreviation ('Investig. New Drugs') can be used for citing, indexing, abstraction, and referencing purposes.
If your area of research or discipline is related to Pharmacology, Pharmacology (medical), Oncology, etc., please check the journal's official website to understand the complete publication process.
There are several factors that influence the acceptance rate of any academic journal. Here are some critical parameters that are considered while calculating the acceptance rate:
The simplest way to find out the acceptance rate or rejection rate of a Journal/Conference is to check with the journal's/conference's editorial team through emails or through the official website.
The latest impact score of Investigational New Drugs is 3.62. It is computed in the year 2023.
The latest h-index of Investigational New Drugs is 94. It is evaluated in the year 2023.
The latest SCImago Journal Rank (SJR) of Investigational New Drugs is 0.943. It is calculated in the year 2023.
The latest ranking of Investigational New Drugs is 4625. This ranking is among 27955 Journals, Conferences, and Book Series. It is computed in the year 2023.
Investigational New Drugs is published by Kluwer Academic Publishers. The publication country of this journal is Netherlands.
This standard abbreviation of Investigational New Drugs is Investig. New Drugs.
Investigational New Drugs is a journal published by Kluwer Academic Publishers.
The scope of Investigational New Drugs is as follows:
For detailed scope of Investigational New Drugs, check the official website of this journal.
The International Standard Serial Number (ISSN) of Investigational New Drugs is/are as follows: 01676997, 15730646.
The best quartile for Investigational New Drugs is Q1.
The coverage history of Investigational New Drugs is as follows 1983-2022.
Note: The impact score shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.
| Journal/Conference/Book Title | Type | Publisher | Ranking | SJR | h-index | Impact Score |
|---|---|---|---|---|---|---|
| European Union Politics | Journal | SAGE Publications Ltd | 2250 | 72 | 2.64 | |
| Journal of Geriatric Physical Therapy | Journal | Lippincott Williams and Wilkins Ltd. | 5578 | 43 | 1.80 | |
| Natural Solutions | Trade Journal | Innovision Health Media | 28581 | 1 | 0.00 | |
| Population Review | Journal | Sociological Demography Press | 17841 | 13 | 0.73 | |
| Indian Phytopathology | Journal | Springer Nature | 14222 | 11 | 1.33 | |
| Asian Textile Journal | Trade Journal | G P S Kwatra | 27455 | 10 | 0.01 | |
| Epigenetics | Journal | Landes Bioscience | 2362 | 105 | 4.11 | |
| Proceedings of the Royal Society of Queensland | Journal | Royal Society of Queensland | 22998 | 12 | 0.48 | |
| Nigerian journal of medicine : journal of the National Association of Resident Doctors of Nigeria | Journal | National Association of Resident Doctors of Nigeria | 25905 | 25 | 0.00 | |
| Psycho-Oncologie | Journal | Springer Paris | 24009 | 11 | 0.13 |
| Year | Impact Score (IS) |
|---|---|
| 2023/2024 | Updated Soon |
| 2022 | 3.62 |
| 2021 | 3.89 |
| 2020 | 3.29 |
| 2019 | 3.52 |
| 2018 | 2.70 |
| 2017 | 3.69 |
| 2016 | 3.71 |
| 2015 | 3.71 |
| 2014 | 3.27 |
3.62
0.943
94
4625
